C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S77-S78
DOI: 10.1016/j.ijrobp.2026.06.086 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von S.V. Porceddu und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Porceddu, S., Day, F., Brungs, D., Christie, H., Jackson, J., Stein, B., Su, Y., Adams, G., Bowyer, S., Yamazaki, N., Bossi, P., Challapalli, A., Ladwa, R., Hauschild, A., Pouliot, J., Seebach, F., Yoo, S., Goncalves, P., Fury, M., & Rischin, D. (2026). C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival. International Journal of Radiation Oncology*Biology*Physics, 126(1), S77-S78. https://doi.org/10.1016/j.ijrobp.2026.06.086
Vancouver
Porceddu S, Day F, Brungs D, Christie H, Jackson J, Stein B, et al. C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S77-S78. doi:10.1016/j.ijrobp.2026.06.086
BibTeX
@article{Porceddu2026,
author = {Porceddu, S.V. and Day, F. and Brungs, D. and Christie, H. and Jackson, J.E. and Stein, B.N. and Su, Y.B. and Adams, G. and Bowyer, S.E. and Yamazaki, N. and Bossi, P. and Challapalli, A. and Ladwa, R. and Hauschild, A. and Pouliot, J. and Seebach, F. and Yoo, S.Y. and Goncalves, P. and Fury, M.G. and Rischin, D.},
title = {C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S77--S78},
doi = {10.1016/j.ijrobp.2026.06.086}
}
EUVIMED